Alerts

Medical Marijuana Card De-activation (A2) - 6/3/21
ASAM Transition Alert (A3) - 6/3/21
SOR Housing Referral Form (A4) - 6/10/21
Relapse Protocols for Recovery House (A5) - 6/17/21
DDAP Alert (A6) - 8/2/21
Medical Marijuana Update (A7) - 8/20/21
Emergency Contact Notification (A8) - 9/3/21
Regulatory Suspensions Notification (A9) - 10/1/21
GPRA: SOR I Closeout Guidance/SOR II Enrollment Process (A10) - 10/5/21
Licensure/Certification Reimbursement (A11) - 10/28/2021
New PA WITS Release Coming November 18th (A12) - 11/10/21
DDAP Licensing Alert 03-2021 (A13) - 12/2/21
Updated Training Requirements (A14) - 12/22/21
GPRA Contingency Management/Reimbursement Alert (A15) - 4/8/22
PA WITS Modality Type Update (A16) - 7/25/22
DDAP Information Bulletin 02-2022 (A17) - 8/24/2022
DEA - Rainbow Fentanyl (A18) - 8/31/2022
Updated Training: Substance Use Disorder Confidentiality (A19) - 9/15/2022
ATLAS Open Enrollment Period (A20) - 10/17/2022
GPRA Case Management Extension (A21) - 10/31/2022
HIV for Substance Use Disorder Professionals (A22) - 11/1/2022
GPRA Contingency Management/Incentives Close Date (A23) - 11/22/2022
DDAP Licensing Alert 03-2022 (A24) - 11/29/2022
Adolescent ASAM Criteria/Xylazine Training Opportunities (A25) - 12/1/2022
DDAP Licensing Alert 03-22: Act 101 of 2022 (A26) - 12/8/2022
New GPRA Tool for SOR-Funded Clients (A27) - 1/20/2023
DDAP's Regulatory Suspensions and End of the COVID-19 Public Health Emergency (A28) - 2/6/2023
Fentanyl Test Strips Alert (A29) - 2/6/2023
Shapiro Administration Urges Medical Assistance, CHIP Recipients to Update Contact Information Ahead of Imminent Federal Changes Impacting Renewals (A30) - 2/6/2023
Workforce Climate Survey (A31) - 2/13/2023
GPRA: Transition to SOR III Funding (A32) - 2/24/2023
Clinical Supervision Training (A33) - 3/9/2023
2023 PA CARES Training Summit (A34) - 3/10/2023
Standardized Program Names coming to PA WITS (A35) - 3/15/2023
Motivational Interviewing - Advancing the Practice workshop (A36) - 3/15/2023
SOR Housing Program (A37) - 3/23/23
MA Unwinding/Renewal Survey (A38) - 3/30/2023
DDAP Additional Trainings (A39) - 4/18/2023
Revised Methadone Take-Home Flexibilities Extension Guidance (A40) - 4/27/2023
Wound Care & Medical Triage for People Who Use Drugs and the Programs That Serve Them (A41) - 4/27/2023
DDAP Licensing Alert 02-2023 - HIV/AIDS Curriculum Content (A42) - 5/5/23
Xylazine Withdrawal and Overdose Best Practices (A43) - 5/17/2023
AOC Policies and Procedures Attestation Form 2022-2023  - 3/29/23
DDAP Licensing Alert 03-2023 - Related to Exception Requests (A43) - 5/24/23
Harm Reduction Survey (A44) - 5/31/23
Substance Use Disorder Treatment and Recovery Loan Repayment Program (A44) - 6/2/23
SUD and PTSD: Research-Based Strategies & Treatments (A45) - 6/6/23
Guidance on Firearms in SUD Treatment Facilities (A46) - 6/8/23
Motivational Interviewing Training: June 22, 2023 (A47) - 6/15/23
DDAP Licensing Alert 04-2023 - Full-time equivalent maximum client/counselor ratios (A48) - 6/14/2023
DEA Federal Register Notice (A49) - 6/27/2023
Provider Town Hall Meetings (A50) - 7/7/2023
HIPAA Data Sharing Project Alert (A51) - 7/10/2023
Invitation to Training: Treating Hepatitis C in SUD Treatment Settings (A52) - 7/11/2023
HRSA Pediatric Specialty Loan Repayment Program (A53) - 7/11/2023
DEA License Surrender (A54) - 7/28/2023
DDAP Technical Assistance Webinars (A55) - 8/21/2023
DDAP New TMS Website Coming- Action Needed (A56) - 8/28/2023
Request for Proposal Provider Listening Session for the Overdose & Substance Use Grief Support Group (A57) - 9/12/2023
Save the Date! DDAP 2023 Emerging Drug Trend Symposium (A58) - 9/26/2023
DDAP 2023 Emerging Drug Trend Symposium November 9, 2023 (A59) - 10/5/2023
Second Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications (A60) - 10/24/2023
New GPRA Tool Alert (A61) - 11/22/2023
DDAP New Training Management System (TMS) (A62) - 11/27/2023
GPRA Interviews In PA WITS (A63) - 12/4/2023

Save a Life: Narcan Drive-Thru Event (P2) - 8/2/21
Medication Take Back: October 23, 2021 (P3) - 9/24/21
Medication Take Back: October 29, 2022 (P4) - 9/29/22
Narcan Training 11/10/2022 (P4) - 11/1/22
Medication Take Back: April 22, 2023 (P5) - 4/14/23
Prevention Day: Wednesday, May 10, 2023 (P6) - 5/1/23
Southeast Regional Overdose Prevention Coalition Conference: December 1, 2023 (P7) - 11/1/2023